Swiss clinical-stage pharmaceutical company NLS Pharmaceutics Ltd has received US Food and Drug Administration (FDA) authorization to proceed with the phase 3 AMAZE program for Quilience (mazindol ER) for narcolepsy treatment. The AMAZE Program will encompass two double-blind phase 3 trials investigating mazindol ER versus placebo in adult patients with narcolepsy, commencing this summer at…
Zevra Therapeutics Inc announced the acceptance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) to begin a phase 1 clinical trial of KP1077 in narcolepsy, which is expected to provide additional information regarding the optimal dosing regimen. The company plans to initiate the first of several phase 1…
A new study shows that sleep spindles, brief bursts of brain activity occurring during one phase of sleep and captured by electroencephalogram, may regulate anxiety in people with post-traumatic stress disorder (PTSD). The study, published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, shines a light on the role of spindles in alleviating anxiety in PTSD…
A new study published in the online issue of Neurology on the impact of daylight savings time on sleep found that sleep problems only occur during the fall time change when getting an extra hour of sleep. The study found the transition from daylight saving time to standard time, when one hour is gained overnight,…
Health Canada has granted marketing authorization for Idorsia Ltd’s Quviviq (daridorexant) for the management of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Quviviq is a dual orexin receptor antagonist acting on both orexin 1 and orexin 2 receptors equipotently. Rather than inducing sleep through broad inhibition of brain activity…
Inspire Medical Systems Inc, a medical technology company focused on the development of solutions for patients with obstructive sleep apnea (OSA), reported first-quarter business highlights, showcasing progress for its OSA therapy. During the quarter, Inspire activated 68 new centers in the US, bringing the total to 973 US medical centers providing Inspire therapy. Additionally, the…
Audio Transcript What makes you the happiest? What are you after? What’s the one main thing that, if you got it, would make you the most joyful person for the longest amount time? Every breathing human being on this planet is on a quest to find a fountain of joy. The whole Bible assumes this…
Jamie Burt (chair of PAVO trustees), Clair Swales (PAVO Chief Executive Officer),Sarah Dale (Mental Health rep) & Tom Jones OBE (High Sheriff of Powys)Owen Griffkin (Participation Officer) and Sarah Dale (Mental Health Representative) share their experiences of the recent Powys Volunteer of the Year Awards night.The annual event is organised by Powys Association of Voluntary Organisations.Owen…
The Therapy for Black Girls Podcast is a weekly conversation with Dr. Joy Harden Bradford, a licensed Psychologist in Atlanta, Georgia, about all things mental health, personal development, and all the small decisions we can make to become the best possible versions of ourselves. What are the guidelines you follow about sharing information about your…